Upload Avatar (500 x 500)
Fan Cheng
646064793@qq.com
English, Chinese
Hubei
Wuhan University
Medical School
  • 1987.09-1992.07 Bachelor of Clinical Medicine, Wuhan University
  • 1995.09-2000.07 PhD in Surgery, Wuhan University
  • 2003.09-2004.04 Advanced Scholar in Urology, University of Nancy, France
  • 2010.02-2011.02 Advanced Scholar in Urology, Nuffield Department of Surgery, University of Oxford, UK
  • 2000.07-2002.11 Attending Physician, Department of Urology, Renmin Hospital of Wuhan University
  • 2002.12-2007.11 Associate Chief Physician, Department of Urology, Renmin Hospital of Wuhan University
  • 2007.12-2013.11 Chief Physician, Department of Urology, Renmin Hospital of Wuhan University
  • 2013.12-2020.11 Chief Physician (Second Level), Department of Urology, Renmin Hospital of Wuhan University
  • 2020.11-Present Chief Physician (First Level), Department of Urology, Renmin Hospital of Wuhan University
  • 2003.12-2010.11 Associate Professor, Department of Urology, Renmin Hospital of Wuhan University
  • 2010.11-Present Professor, Department of Urology, Renmin Hospital of Wuhan University
  • 2004.07-Present Master's Supervisor, Department of Urology, Renmin Hospital of Wuhan University
  • 2013.06-Present Doctoral Supervisor, Department of Urology, Renmin Hospital of Wuhan University
  • 2014.12-2022.10 Deputy Director, Department of Urology III, Renmin Hospital of Wuhan University
  • 2022.10-Present Director, Department of Urology, Renmin Hospital of Wuhan University
  • 2017.10-2022.01 Assistant to the President, Renmin Hospital of Wuhan University
  • 2022.01-Present Vice President, Renmin Hospital of Wuhan University
  • 2017 Second Prize of Hubei Province Science and Technology Progress Award (First Complete Person)
  • 2021 Second Prize of Hubei Province Translational Medicine Innovation Award (First Complete Person)
  • 2022 First Prize of Hubei Province Science and Technology Progress Award (First Complete Person)
Minimally invasive treatment of urinary calculi
Mechanism and protection of hydronephrosis renal function injury
Early diagnosis and treatment of bladder tumors
  • Histone H3K27 methyltransferase EZH2 regulates apoptotic and inflammatory responses in sepsis-induced AKI, Li B, Xia Y, Mei S, et al., 2023
  • p53 deacetylation alleviates calcium oxalate deposition-induced renal fibrosis by inhibiting ferroptosis, Ye Z, Xia Y, Li L, et al., 2023
  • TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-κB, Xing J, Chen W, Chen K, et al., 2022
  • Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer, Zhu S, Ma AH, Zhu Z, et al., 2021
  • Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys, Zhao S, Li W, Yu W, et al., 2021
  • Tubular cell-derived exosomal miR-150-5p contributes to renal fibrosis following unilateral ischemia-reperfusion injury by activating fibroblast in vitro and in vivo, Zhou X, Zhao S, Li W, et al., 2021
  • Long Non-coding RNA MEG3 Promotes Pyroptosis in Testicular Ischemia-Reperfusion Injury by Targeting MiR-29a to Modulate PTEN Expression, Ning JZ, He KX, Cheng F, et al., 2021
  • Construction and Analysis of Immune Infiltration-Related ceRNA Network for Kidney Stones, Xia Y, Zhou X, Ye Z, et al., 2021
  • miR-132-3p promotes the cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells by targeting SIRT1 via the NF-κB pathway, Han S, Lin F, Ruan Y, et al., 2021
  • Clinical features and short-term outcomes of elderly patients with COVID-19, Li P, Chen L, Liu Z, et al., 2020
  • Deep learning-based pancreas segmentation and station recognition system in EUS: development and validation of a useful training tool (with video), Zhang J, Zhu L, Yao L, et al., 2020
  • Integrative analysis reveals CRHBP inhibits renal cell carcinoma progression by regulating inflammation and apoptosis, Yang K, Xiao Y, Xu T, et al., 2020
  • AID modulates carcinogenesis network via DNA demethylation in bladder urothelial cell carcinoma, Li H, Li Q, Ma Z, et al., 2019
  • HO-1 Contributes to Luteolin-Triggered Ferroptosis in Clear Cell Renal Cell Carcinoma via Increasing the Labile Iron Pool and Promoting Lipid Peroxidation, Han S, Lin F, Qi Y, et al., 2022
  • A Novel Gene Signature of Tripartite Motif Family for Predicting the Prognosis in Kidney Renal Clear Cell Carcinoma and Its Association With Immune Cell Infiltration, Zheng D, Zhang Y, Xia Y, Cheng F, 2022
  • Comparison of the effectiveness and safety of ureteroscopic lithotripsy and micro-channel percutaneous nephrolithotomy for treating <1.5 cm stones in the lower calyx of the kidney, Zhu Chengcun, Cheng Fan, Yu Weimin, et al., 2023
  • Classification and clinical value of the posterior renal calyx, Qi Yucheng, Xiong Zhuang, Lin Fangyou, et al., 2022
  • The role and mechanism of CXCR4 in renal injury and fibrosis caused by calcium oxalate crystals, Ye Zehua, Xia Yuqi, Li Baijun, et al., 2022
  • Relationship between different percutaneous renal access paths and renal vascular injury, Lin Fangyou, Cheng Fan, Rao Ting, et al., 2020
  • Fusion of renal papillary anatomy and its appearance in ultrasound and CT examinations, Xia Yuqi, Cheng Fan, Rao Ting, et al., 2019
Urology Minimally Invasive Kidney Stones Hydronephrosis Renal Function Bladder Cancer Early Diagnosis Treatment Surgical Techniques Clinical Application

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.